Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation
ConclusionsAltogether, these results suggest ofatumumab has a poor efficacy in treating recurrence of NS after renal transplantation. However, it could be discussed in multidrug-resistant refractory NS, but infectious complications and overimmunosuppression have to be balanced. There is a need for further studies to confirm these findings and safety and to determine a standardized protocol in this indication.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Children | France Health | Multidrug Resistance | Nephrotic Syndrome | Pediatrics | Proteinuria | Study | Transplants | Urology & Nephrology